Losing Your Job Means Losing GLP-1 Coverage - Your Real Options
Most "losing your job" health-insurance content is generic. This page is specifically about what happens to a GLP-1 prescription - because the honest answer involves a program gap (patient assistance) that several other sites get wrong.
The patient-assistance program gap nobody mentions
Both major manufacturers run real, legitimate patient-assistance programs (PAPs) for uninsured patients - but neither covers the weight-loss drug you are probably taking:
- Novo Nordisk's PAP covers Ozempic (the diabetes-indicated version of semaglutide) and insulin products. Wegovy is not on the covered list.
- Lilly Cares Foundation's PAP covers Trulicity (an older diabetes GLP-1). Zepbound, Mounjaro, and Foundayo are not on the covered list.
If you see a site claiming you can get "free Zepbound" or "free Mounjaro" through Lilly Cares, that claim does not match the program's own published medication list. The one real exception is Novo Nordisk's one-time, lifetime-limited free 28-day Wegovy starter fill for new patients with a documented MASH diagnosis - a narrow clinical program, not a general safety net.
COBRA: what it costs, how long it lasts, and the catch
Cost:up to 102% of your plan's full premium - your former employee contribution, plus what your employer was paying, plus a 2% administrative fee. There is no single reliable national average, but a real 2026 state-employee COBRA rate schedule charges roughly $1,000/month for individual coverage and $2,940/month for family coverage on a standard plan; expect somewhere in the $800-$3,000/month range depending on your former plan and household size. Get your exact number from your former employer's HR or COBRA administrator.
Duration: 18 months for a standard job loss or reduction in hours - not 36 months, which only applies to unrelated triggering events (Medicare entitlement, divorce, death, a dependent aging out). An 18-month period can extend to 29 months with an SSA disability determination made within the first 60 days.
The catch: COBRA guarantees you the same coverage active employees currently have- not the plan design frozen as of your layoff date. If your former employer later tightens or drops GLP-1 coverage for its active workforce, that change applies to you on COBRA at the same time. Employer GLP-1 coverage has been genuinely unstable through 2026: benefits surveys from Mercer and the Business Group on Health, reported by CNBC, found a meaningful share of large employers either dropped weight-loss GLP-1 coverage in 2026 or are considering dropping it for 2027, and many that keep it are raising BMI thresholds or narrowing to diabetes-only. COBRA is not protection against your former employer's own future coverage decisions.
The ACA Marketplace alternative
Losing job-based coverage opens a 60-day-before, 60-day-after Special Enrollment Period on the ACA Marketplace, regardless of whether you quit, were laid off, or were fired - the trigger is losing the coverage itself, not the reason you left your job (45 CFR § 155.420). Electing COBRA first does not forfeit this window: if you take COBRA and later let it lapse, that lapse can open a new 60-day enrollment window.
Two things to check before assuming a Marketplace plan solves the problem. First, coverage: only about 8.7% of 2026 Marketplace carriers cover a GLP-1 for obesity at all, concentrated in 9 states - see the full state-by-state breakdown before you enroll expecting coverage. Second, subsidy cost: enhanced ACA premium tax credits expired January 1, 2026, and had not been extended as of the most recently available information - the subsidy "cliff" at 400% of the federal poverty level is back, meaning a decent pre-layoff income this year could push you above the threshold for any premium subsidy at all. Run the actual numbers on healthcare.gov before assuming Marketplace is affordable.
If nothing covers you: the direct cash-pay paths
These require no insurance, no income verification, and no application - you pay the posted price directly:
- NovoCare (Wegovy): $349/month standard, or $149/month for the oral tablet's lower titration doses.
- LillyDirect (Zepbound): $299/month starting at the 2.5 mg dose.
- TrumpRx.gov: a federal cash-pay portal launched February 2026 following a Most-Favored-Nation pricing agreement, listing direct cash prices for Zepbound and Mounjaro with no application process.
Full channel-by-channel breakdowns: Wegovy without insurance · Zepbound without insurance
Frequently asked questions
Can I get Wegovy or Zepbound free through a manufacturer patient assistance program if I lose my insurance?
No - and this is worth stating plainly because several other sites claim otherwise. Novo Nordisk's Patient Assistance Program (PAP) covers Ozempic (the diabetes-indicated version of semaglutide) and its insulin products, but Wegovy is not on the covered-medication list. Eli Lilly's Lilly Cares Foundation PAP covers Trulicity (an older diabetes GLP-1) but not Zepbound, Mounjaro, or Foundayo. Both programs are real and well-documented on the manufacturers' own sites - they simply do not extend to the weight-loss-indicated drugs. The one narrow exception: Novo Nordisk offers a one-time, lifetime-limited free 28-day starter fill of Wegovy for new patients with a documented MASH (metabolic dysfunction-associated steatohepatitis) diagnosis - not a general coverage-gap bridge.
Does COBRA keep my exact same GLP-1 coverage from before I lost my job?
Not necessarily, and this catches people off guard. COBRA guarantees you the same coverage as active employees currently have - not the coverage design frozen as of your last day. If your former employer changes its GLP-1 policy (tightens BMI thresholds, drops a drug, adds new prior-authorization requirements) for its active employees, that same change applies to you on COBRA at the same time. Employer GLP-1 coverage has been genuinely unstable through 2026 - multiple employer-benefits surveys (Mercer, Business Group on Health, reported by CNBC) found a meaningful share of large employers either dropped or are considering dropping weight-loss GLP-1 coverage for 2027, and many that keep it are raising BMI thresholds or restricting to diabetes-only. COBRA is not insurance against your former employer's own future coverage decisions.
How much does COBRA actually cost per month?
By law (26 CFR § 54.4980B-8), COBRA premiums can run up to 102% of the full cost of the plan - your previous employee share, plus what your employer was paying on your behalf, plus a 2% administrative fee. There is no single reliable national average dollar figure, but applying that 102% rule to the 2025 KFF Employer Health Benefits Survey's reported average total premiums works out to roughly $790/month for individual coverage and $2,290/month for family coverage - and a real, published 2026 state-employee COBRA rate schedule (Minnesota) charges $998.60/month individual and $2,936.56/month family for a standard PPO-style plan, which is in the same range. Expect COBRA to run somewhere in the $800-$3,000/month range depending on your former plan's richness and whether you are covering a family - request your specific COBRA rate from your former employer's HR or benefits administrator rather than assuming a number.
Is COBRA available for 18 months or 36 months after a layoff?
For a straightforward job loss or reduction in hours - the scenario most people are in - COBRA runs 18 months, not 36. The 36-month window applies only to different triggering events entirely (a covered employee becoming Medicare-eligible, divorce, death, or a dependent aging out of the plan), not to losing your job. The 18-month period can extend to 29 months if Social Security determines you disabled within the first 60 days of COBRA coverage (at a higher premium cap of 150% instead of 102% for the disabled individual), or to 36 months if a second qualifying event happens during that window. Plan around 18 months unless one of those specific extensions applies to you.
Can I skip COBRA and go straight to the ACA Marketplace instead?
Yes. Losing job-based coverage is a qualifying life event that opens a Special Enrollment Period on the ACA Marketplace regardless of whether you quit, were laid off, or were fired - the trigger is losing the coverage, not why you lost your job. You get 60 days before and 60 days after your coverage-loss date to enroll, per 45 CFR § 155.420. Electing COBRA first does not forfeit this window either - if you take COBRA and later let it lapse, that lapse itself can open a new 60-day Marketplace enrollment window. The real question is not COBRA-vs-Marketplace eligibility - it is whether a Marketplace plan actually covers your GLP-1 (see the next question).
Will an ACA Marketplace plan cover my GLP-1 after I switch from COBRA?
Possibly not - check before you assume it will. Only about 8.7% of 2026 ACA Marketplace carriers cover a GLP-1 for obesity at all, concentrated in just 9 states. See the full breakdown on /aca-marketplace-glp1-coverage before you commit to a Marketplace plan expecting your GLP-1 to be covered. Also factor in cost: enhanced ACA premium tax credits expired January 1, 2026 and had not been extended as of the most recent information available, meaning the subsidy "cliff" at 400% of the federal poverty level is back - if your household income (including what you earned before the layoff this year) puts you above that threshold, you may not qualify for any premium subsidy on top of a plan that might not even cover the drug.
What is the actual cheapest path if nothing covers me?
Direct manufacturer cash-pay, the same channel available to anyone without insurance. NovoCare (Wegovy) runs $349/month standard for the injection or $149/month for the oral tablet's lower titration doses; LillyDirect (Zepbound) starts at $299/month for the 2.5 mg starter dose. Neither requires insurance, income verification, or an application - you pay the posted price. A newer option, trumprx.gov (a federal cash-pay portal launched February 2026 following a Most-Favored-Nation pricing agreement), also lists direct cash pricing for Zepbound and Mounjaro with no application process. See the full without-insurance breakdowns linked below for your specific drug.
Sources
- 26 CFR § 54.4980B-8 and CMS.gov COBRA fact sheet (premium cap mechanics).
- DOL.gov COBRA FAQ (election windows, coverage-parity rules).
- 45 CFR § 155.420 (ACA Marketplace Special Enrollment Period rules).
- CRS Report R48290 (enhanced premium tax credit expiration and 2026 subsidy landscape).
- Novo Nordisk Patient Assistance Program application (novocare.com) and Lilly Cares Foundation application (lillycares.com), cross-checked against RxAssist.
- CNBC reporting (2026) on Mercer and Business Group on Health employer benefits surveys.
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.